Please use this identifier to cite or link to this item:
DC FieldValue
dc.titleIn-practice predictors of response to proton pump inhibitor therapy in primary care patients with dyspepsia in an Asian population
dc.contributor.authorGwee, K.-A.
dc.contributor.authorHwang, J.E.-H.
dc.contributor.authorHo, K.-Y.
dc.contributor.authorYeoh, K.-G.
dc.contributor.authorLum, C.-F.
dc.contributor.authorAng, P.-K.
dc.identifier.citationGwee, K.-A., Hwang, J.E.-H., Ho, K.-Y., Yeoh, K.-G., Lum, C.-F., Ang, P.-K. (2008-02). In-practice predictors of response to proton pump inhibitor therapy in primary care patients with dyspepsia in an Asian population. Journal of Clinical Gastroenterology 42 (2) : 134-138. ScholarBank@NUS Repository.
dc.description.abstractBACKGROUND: Data on Asian patients who present to primary care physicians with dyspepsia are limited. AIM: To determine predictors of response to a trial of proton pump inhibitor therapy. METHOD: One hundred ninety patients presenting to their general practitioners with dyspeptic symptoms but without alarm symptoms, underwent endoscopy and were subsequently treated with 20 mg of esomeprazole twice a day for 2 weeks. Possible predictors of response were assessed before treatment. Dyspeptic symptoms were scored at baseline and at the end of treatment. Excellent response and poor response were defined as end of treatment score of ≤1 and failure to achieve ≥50% reduction in symptom scores. RESULTS: On bivariate analysis male sex and having ≤2 concurrent dyspeptic symptoms predicted excellent response, whereas bloating as most bothersome symptom, >2 dyspeptic symptoms, anxiety, and irritable bowel syndrome predicted poor response. On multivariate analysis, male sex and ≤2 dyspeptic symptoms, and bloating remained significant predictors of excellent and poor responses, respectively. CONCLUSIONS: Predictors of response to proton pump inhibitor trial that could be easily assessed in a primary care clinic were identified. In our population the response was not as favorable as suggested by clinical trials. Frequent overlap with irritable bowel syndrome seems to be an important factor. © 2008 Lippincott Williams & Wilkins, Inc.
dc.subjectGastroesophageal reflux
dc.subjectIrritable bowel syndrome
dc.subjectPrimary care
dc.subjectProton pump inhibitor
dc.description.sourcetitleJournal of Clinical Gastroenterology
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.